Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials

Reviews in Urology

Elisabeth Eckersberger¹  Markus Margreiter¹  Herbert Lepor¹  Julia Finkelstein¹  Helen Sadri¹  Samir S Taneja¹  Bob Djavan¹ 

[1] Department of Urology, School of Medicine, New York University, New York, NY

关键词: PSA screening;    European Randomized Study of Screening for Prostate Cancer (ERSPC);    Prostate;    Lung;    Colorectal;    and Ovarian (PLCO) Cancer Screening Trial;   

DOI  :  

学科分类：基础医学

来源: MedReviews, LLC

【 摘 要 】

The advent of prostate-specific antigen (PSA) testing in the early 1980s revolutionized the diagnosis of prostate cancer. As a result of PSA testing, there has been a surge in the number of prostate cancer diagnoses. This review examines the results of 2 recent landmark trials that studied the effect of screening on prostate cancer mortality: the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the US-based Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

【 授权许可】

Unknown